We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
- Authors
Sever, Peter S; Dahlöf, Björn; Poulter, Neil R; Wedel, Hans; Beevers, Gareth; Caulfield, Mark; Collins, Rory; Kjeldsen, Sverre E; Kristinsson, Arni; McInnes, Gordon T; Mehlsen, Jesper; Nieminen, Markku; O'Brien, Eoin; Ostergren, Jan; ASCOT investigators
- Abstract
The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol lowering in the primary prevention of coronary heart disease (CHD) in hypertensive patients who are not conventionally deemed dyslipidaemic.
- Publication
Lancet (London, England), 2003, Vol 361, Issue 9364, p1149
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(03)12948-0